XPhyto Therapeutics
| XPhyto Therapeutics Corp. | |
|---|---|
| legal form | Corp. |
| ISIN | CA98421R1055 |
| founding | 2017 |
| Seat | Vancouver |
| management | Hugh Rogers |
| sales | 208,119 Canadian dollars (2019) |
| Website | xphyto.com |
The XPhyto Therapeutics Corp. is a publicly traded Canadian company. XPhyto specializes in the formulation, clinical validation and growth markets for cannabis in Europe.
Activities in Germany
Bunker plant extracts
The bunker plant extracts GmbH in Memmingen has received a license for the cultivation and extraction of cannabis for research purposes in Germany. A former bunker on the Memmingen airport site is to be used by the company for growing cannabis.
Vector Pharma TF
The vector Pharma GmbH TF in Uttenweiler is a manufacturing, import and research firm for narcotics. The company, founded in 2009, has been part of XPhyto Therapeutics since 2020.
Individual evidence
- ↑ Consolidated Financial Statements, accessed on June 30, 2020
- ↑ Company profile on www.sedar.com
- ↑ Marc Davis: XPhyto: Why Germany is the right place at the right time , in wallstreet-online.de on September 13, 2019, May 13, 2020
- ↑ welt.de of October 31, 2017
- ↑ www.finanznachrichten.de of March 3, 2020